Back to company

CPHbiomedix ApS: Financial statements 2022

CVR: 43118676

CPHbiomedix ApS (CVR 43118676) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,341,829 and a net result of DKK 313,910. Equity amounted to DKK 3,060,393. The solvency ratio was 92.6%. The company had 1 employee in the financial year.

Gross Profit
1,341,829 kr.
Profit/Loss
313,910 kr.
Equity
3,060,393 kr.
Total Assets
3,304,571 kr.
Employees
1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CPHbiomedix ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Claus Bo Vöge Christensen joins CPHbiomedix ApS as directorMar 11, 2022

As of March 11, 2022, Claus Bo Vöge Christensen is registered as director of CPHbiomedix ApS.

Claus Bo Vöge Christensen registered as owner of CPHbiomedix ApSMar 11, 2022

As of March 11, 2022, Claus Bo Vöge Christensen is registered as an owner of CPHbiomedix ApS with an ownership share of 100%.

CPHbiomedix ApS is foundedMar 11, 2022

CPHbiomedix ApS was founded on March 11, 2022.

About CPHbiomedix ApS

CPHbiomedix ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Claus Bo Vöge Christensen. The company is owned by Claus Bo Vöge Christensen. In 2025, the company reported a gross profit of DKK 473,967 and a net result of DKK -21,956 compared with DKK 237,468 the year before. Equity amounted to DKK 3,555,387.

Other financial years